Literature DB >> 23407766

Phenotypic and molecular characterisation of type 3 von Willebrand disease in a cohort of Indian patients.

Firdos Ahmad1, Ulrich Budde, Rifat Jan, Florian Oyen, Meganathan Kannan, Renu Saxena, Reinhard Schneppenheim.   

Abstract

Severe type 3 VWD (VWD3) is characterised by complete absence or presence of trace amounts of non-functional von Willebrand factor (VWF). The study was designed to evaluate the VWF mutations in VWD3 patients and characterise the breakpoints of two identified homozygous novel large deletions. Patients were diagnosed by conventional tests and VWF multimer analysis. Mutation screening was performed in 19 VWD3 patients by direct sequencing of VWF including flanking intronic sequence and multiplex ligation-dependent probe amplification (MLPA) analysis. Breakpoint characterisation of two identified novel large deletions was done using walking primers and long spanning PCR. A total of 21 different mutations including 15 (71.4%) novel ones were identified in 17 (89.5%) patients. Of these mutations, five (23.8%) were nonsense (p.R1659*, p.R1779*, p.R1853*, p.Q2470*, p.Q2520*), one was a putative splice site (p.M814I) and seven (33.3%) were deletions (p.L254fs*48, p.C849fs*60, p.L1871fs*6, p.E2720fs*24) including three novel large deletions of exon 14-15, 80,830bp (-41510_657+7928A*del) and 2,231bp [1534-2072T_c.1692G*del(p.512fs*terminus)] respectively. A patient carried gene conversion comprising of pseudogene harbouring mutations. The missense mutations (p.G19R, p.K355R, p.D437Y, p.C633R, p.M771V, p.G2044D, p.C2491R) appear to play a major role and were identified in seven (36.8%) patients. In conclusion, a high frequency of novel mutations suggests the high propensity of VWF for new mutations. Missense and deletion mutations found to be a common cause of VWD3 in cohort of Indian VWD3 patients. Breakpoints characterisation of two large deletions reveals the double strand break and non-homologous recombination as deletions mechanism.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23407766     DOI: 10.1160/TH12-10-0737

Source DB:  PubMed          Journal:  Thromb Haemost        ISSN: 0340-6245            Impact factor:   5.249


  8 in total

1.  Characterization of large in-frame von Willebrand factor deletions highlights differing pathogenic mechanisms.

Authors:  Ashley Cartwright; Simon J Webster; Annika de Jong; Richard J Dirven; Lisa D S Bloomer; Ahlam M Al-Buhairan; Ulrich Budde; Christer Halldén; David Habart; Jenny Goudemand; Ian R Peake; Jeroen C J Eikenboom; Anne C Goodeve; Daniel J Hampshire
Journal:  Blood Adv       Date:  2020-07-14

Review 2.  New insights into genotype and phenotype of VWD.

Authors:  Veronica H Flood
Journal:  Hematology Am Soc Hematol Educ Program       Date:  2014-11-18

3.  von Willebrand factor propeptide variants lead to impaired storage and ER retention in patient-derived endothelial colony-forming cells.

Authors:  Mackenzie Bowman; Lara Casey; Soundarya N Selvam; Patricia D A Lima; Orla Rawley; Megan Hinds; Angie Tuttle; Julie Grabell; Alfonso Iorio; Irwin Walker; David Lillicrap; Paula James
Journal:  J Thromb Haemost       Date:  2022-05-03       Impact factor: 16.036

4.  p.P2063S: a neutral VWF variant masquerading as a mutation.

Authors:  Daniel J Hampshire; Anne C Goodeve
Journal:  Ann Hematol       Date:  2013-06-18       Impact factor: 3.673

5.  Genetic heterogeneity in a large cohort of Indian type 3 von Willebrand disease patients.

Authors:  Priyanka Kasatkar; Shrimati Shetty; Kanjaksha Ghosh
Journal:  PLoS One       Date:  2014-03-27       Impact factor: 3.240

6.  Genotypes of European and Iranian patients with type 3 von Willebrand disease enrolled in 3WINTERS-IPS.

Authors:  Luciano Baronciani; Ian Peake; Reinhard Schneppenheim; Anne Goodeve; Minoo Ahmadinejad; Zahra Badiee; Mohammad-Reza Baghaipour; Olga Benitez; Imre Bodó; Ulrich Budde; Andrea Cairo; Giancarlo Castaman; Peyman Eshghi; Jenny Goudemand; Wolf Hassenpflug; Hamid Hoorfar; Mehran Karimi; Bijan Keikhaei; Riitta Lassila; Frank W G Leebeek; Maria Fernanda Lopez Fernandez; Pier Mannuccio Mannucci; Renato Marino; Nikolas Nikšić; Florian Oyen; Cristina Santoro; Andreas Tiede; Gholamreza Toogeh; Alberto Tosetto; Marc Trossaert; Eva M K Zetterberg; Jeroen Eikenboom; Augusto B Federici; Flora Peyvandi
Journal:  Blood Adv       Date:  2021-08-10

7.  Two cases of von Willebrand disease type 3 in consanguineous Chinese families.

Authors:  Xiong Wang; Ning Tang; Yanjun Lu; Qun Hu; Dengju Li
Journal:  Mol Genet Genomic Med       Date:  2019-12-02       Impact factor: 2.183

8.  A Homozygous Deep Intronic Variant Causes Von Willebrand Factor Deficiency and Lack of Endothelial-Specific Secretory Organelles, Weibel-Palade Bodies.

Authors:  Hamideh Yadegari; Muhammad Ahmer Jamil; Natascha Marquardt; Johannes Oldenburg
Journal:  Int J Mol Sci       Date:  2022-03-13       Impact factor: 5.923

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.